January 30th: Northern California BioPharmaceutical Project Management Networking Social

Resolve to expand your network in 2014!  Kick-off the new year by making new professional connections and deepening existing ones.

When:      January 30, 2014

6:00-8:30 PM

Where:    Porterhouse Restaurant

60 E. Third Ave.

San Mateo, CA, 94401

Pricing:   $20 pre-registration by January 22

$30 walk-in (cash only)

Registration: http://ncbppmjanmixer.eventzilla.net

Join us in the bar and lounge for an evening of delicious appetizers and free-flowing networking. Cash bar. 

Enjoy a relaxed evening out socializing and catching up on the latest industry buzz with your fellow professionals in biotech.

Contact: http://norcalbppm.blogspot.com/p/contact-us.html

November 15th: Northern California BioPharmaceutical Project Management Breakfast Meeting

Order vs. Chaos:  A Role for Research Project Management

Speaker:  Richard Wilson, Associate Director, Project and Alliance Management, Theravance, Inc.

Time:  8:00-10:00 AM, presentation begins at 8:30 sharp

Place:  Genentech, room 42-1C, 475 East Grand Ave, South San Francisco, CA 94080

RSVP:  http://www.eventzilla.net/web/event?EventID=2139006724

Abstract:

When combining the disciplines of Project Management and Pharmaceutical Research, many challenges arise that are not commonly faced in the realm of more mature development stage projects.  This talk will endeavor to shed some light on the unique challenges and areas of potential conflict that go along with working in the early stage project arena (with a particular focus on the transition from late stage research into preclinical development) and describe some of the approaches that can be taken for a project manager to add value to research project teams.

Some selected themes:

• PMBOK vs Research culture – Is there any common ground?
• Understanding the difference between research and development project mindsets
• Why (and when) research teams should seek out project management support
• Opportunities to strengthen the bonds between research projects and the business

Speaker Bio:

Richard has over 20 years experience in Pharmaceutical Research and Early Development with Glaxo, BioChem Pharma and Theravance (since 2000).  A chemist by training, he has held positions in medicinal chemistry, process chemistry, held the role of CMC team leader, project leader, and also initiated a CRO selection and management process at Theravance in 2008 and 2009.  Since 2010, his focus within Theravance has been to define a Project Management role for in-house early stage projects, and to provide Project and Alliance Management expertise to a variety of partnered programs.

Additional Information:

• Genentech requires valid photo ID upon checking
• Due to strict Genentech policies, registration closes at midnight Nov 11th - no exceptions, no walk-ins
• 2 PDUs for PMP re-certification may be claimed for attendance

October 22nd: Joint Northern California BioPharmaceutical Project Management and Silicon Valley Association of Strategic Alliance Professionals Panel Discussion

Key Value Drivers across the Biopharmaceutical Alliance Lifecycle:  

Maximizing stage-gate driven value in a tough regulatory and funding environment, from joint R&D ventures to co-commercialization. 

Biopharmaceutical alliance leaders are responsible for managing risk and complexity throughout an alliance lifecycle. At key hand-off points over various stages of research and development through commercialization, this may require revising the partnership plan to:

• Achieve new outcomes
• Redefine measures of success
• On-board and off-board stakeholders
• Restructure the partnership governance

Our distinguished panel of experts will address these challenges and others in these key areas:

Value-

• What are the key value drivers at different stages of the lifecycle of a biopharmaceutical partnership?
• How to optimize partnership value across lifecycle Inflection Points?
• How each stakeholder adds unique value to the alliance partnership?

Lifecycle-

• What are the key alliance success factors that transcend lifecycle inflection points as well as corporate handoffs?
• How does the alliance leaders manage the interdependence among functions throughout the project?

Trends-

• What are some current industry trends in alliances and partnerships?
• What key elements are driving these trends?
• What factors are influencing the decision makers behind the deals?

Panelists:

Titus Plattel, VP of Corporate Development, Bavarian Nordic-ImmunoTherapeutics

Janice Babia-Ramos, Group Product Director, Alliance Management Oncology at Janssen

Lisa Hagerty-McMahon, Principal & Owner Hagerty-McMahon Consulting

Chapter President, Northern California BioPharma PM

Moderator:

Norma Watenpaugh, Principal Phoenix Consulting Group

Global Board Member, Association of Strategic Alliance Professionals

Event Details:

Date: Tuesday October 22^nd, 2013

Time: 5:30 - 9:00 pm

• 5:30 – 6:30 Networking 
• 6:30 – 7:30 Dinner
• 7:30 – 8:30 Panel 
• 8:30 – 9:00 Q&A / Close / Networking

Location: Terrace Café, El Rancho Suites Inn, 1100 El Camino Real, Millbrae

Register online: http://bppmasap22oct13dinner.eventzilla.net
.
Deadline to RSVP:  Monday October 21^st
Seating is limited and early registration is recommended. Tickets will be unavailable once seating is sold out
Pricing:  
$35 by October 21^st (includes dinner and non-alcoholic beverages)
$45 at the Door

Questions/Comments: norcalbiopharma@gmail.com